Jeff Simmons

Jeff Simmons Portrait

Since 2008, Jeff Simmons has served as president of Elanco, the animal health division of Eli Lilly and Company, (NYSE: LLY). As part of this role, he is also a Senior Vice President and Executive Officer of Lilly. Elanco is an innovation-driven company with offices in more than 75 countries and 2012 sales of over $2.0 billion. The company is committed to protein production; companion animal health and food safety, with an emphasis on helping the food industry produce a safe and affordable food supply.

In more than two decades with the company, Simmons has held a number of sales, marketing and management positions, in the United States and abroad, including serving as country director in Brazil and area director for West Europe based in the U.K.

These international experiences offered Simmons a new perspective on food and agriculture and created a deep conviction about the need for solutions to global food security. He has published white papers on this topic and actively engages in food security discussions in social media (@jeffsimmons2050).  

Simmons also holds a number of leadership positions, including serving on the board of directors for Chiquita, Gleaners Food Bank of Central Indiana and the current President of the International Federation of Animal Health (IFAH). He is also a member of Harvard’s Food Advisory Committee.


Rob Aukerman
President-U.S. and Canada Operations

Rob Aukerman Portrait

Rob Aukerman is the President of the U.S. and Canada Operations at Elanco Animal Health.  He has led the U.S. business since May 2007 and recently added Canadian operations.  

Since joining Elanco in 1992, Aukerman has held a number of senior management positions within the company, including director of innovation strategy, area director for the Pacific Rim and senior director of global marketing.

Aukerman earned a bachelor’s degree in psychology from Asbury College in 1981. After working for three years in his family’s dairy business and serving eight years in the feed industry, he joined Elanco, a division of Eli Lilly and Company.

Aukerman currently serves on the Board of Directors and Executive Committee of the Animal Health Institute and on the Children’s Organ Transplant Association (COTA) Board of Directors.

Rob and his wife, Betty, have ten children and reside near Indianapolis, IN.


Claudia Garcia
Senior Director, Marketing Access

Claudia Garcia Portrait

Claudia Garcia leads Global Corporate Affairs for Elanco. As part of this role, Ms. Garcia and her team oversee:

  • Global government affairs
  • Food industry & consumer affairs
  • Global communications
  • Shared value

Ms. Garcia brings to her position 20 years of experience in animal health, including multiple positions within Elanco. She initiated her professional career with Elanco in Mexico and later transferred to the USA, where she held positions in manufacturing and sales and marketing.

In her two most recent assignments, she served as senior director in Global Marketing and area director for Canada and Latin America. Her priority was selecting and developing talent to collaborate with key customers.

She holds a doctorate of veterinary medicine and animal science from the National University of Mexico (U.N.A.M). She received the university’s public health award for her internship in social service to diagnose rabies in a faster, more economical way. 

Eric Graves
Chief Marketing Officer

Eric Graves Portrait

Eric Graves is Chief Marketing Officer of Elanco, the animal health division of Eli Lilly and Company.  He joined Elanco in 2003 and is responsible for all aspects of marketing for Elanco’s existing and new products and brands.  

Eric has been the Chief Marketing Officer of Elanco since January 2013.  Prior to that role, he was responsible for Elanco’s launch into the companion animal market.  Eric is passionate about building teams and applying a practical approach to marketing that results in real value to customers.

Prior to joining Elanco, Eric served as director of veterinary marketing at Hill’s Pet Nutrition, Inc., a division of Colgate-Palmolive. Before joining Hill’s, he was a marketing director of companion animal products at Merial. He also served in a range of marketing, sales and operations roles at Merial and Merck Agvet.

Eric serves on the board of the Banfield Charitable Trust, an organization dedicated to keeping pets and their people together when facing challenging situations.

Eric earned degrees in marketing and science from Pennsylvania State University and has received executive training from Columbia University in marketing management and the Wharton School of Business in new product development.

Steve Jenison
Vice President, Manufacturing

Steve Jenison Portrait

Stephen H. Jenison is the Vice President of Elanco Manufacturing.  In this position, Steve has a dual reporting relationship to Maria Crowe, President of Manufacturing Operations and Jeff Simmons, President of Elanco Animal Health.  He oversees internal manufacturing operations at facilities in the United States, Britain, and Ireland.  In addition, he oversees Elanco’s global external manufacturing operations and supply chain organization.

Born in Paris, Illinois, Jenison was awarded a Bachelor of Science degree in chemical engineering from Rose-Hulman Institute of Technology in 1981, and a master in business administration from the University of Kansas in 1985.

Jenison joined Lilly in 1986 as a technical service representative in Clinton Laboratories. He also held positions at Clinton as financial analyst and department head of chemical operations prior to becoming manager - North East Regional distribution center in Enfield, Connecticut in 1990. In 1991, he was named the development projects manager in LRL for Gemzar. Jenison moved to Puerto Rico in 1992 as the Mayaguez site head.  In 1995 he returned to various manufacturing strategy roles with the global business units and product teams.  Prior to becoming the senior manufacturing business lead for the Global Business Integration Project (GBIP) he had a short stint as Executive Director for the Indianapolis Pharmaceutical Operations.  From 2004-2009 Steve was the Vice President and Manufacturing Information Officer for Global Manufacturing.  In 2010, he began a dual reporting relationship to both Myles O’Neill, Senior Vice President of Global Drug Product and Jacques Tapiero, President of Emerging Markets.  During that position he served as the Vice President of Emerging Markets and External Drug Product Operations.  Prior to joining Lilly, Jenison held various positions in the inorganic chemicals industry.

Jade Kas
Senior Director-Human Resources

Jade Kas Portrait

Jade Kas was named to his current position in April 2013. He joined Eli Lilly and Company in 1999 and spent his first 4 yrs in both a sales and sales operations roles.

During the past 10 years, he has held a variety of roles in Human Resources supporting sales and marketing, global compensation, mergers and acquisitions, employee relations, and manufacturing. In his most recent role, Jade has been supporting Elanco as the Sr. Director of HR for Elanco Mfg.

Jade holds a bachelor's degree in Business Management & HR Management from IUPUI.

Brian Kopp
CFO and VP of Strategy and Operations

Brian Kopp Portrait

Since 2007, Brian Kopp has served as CFO of Elanco. Mr. Kopp has been with Eli Lilly and Company for 17 years, holding a variety of positions, including:

  • Director and senior director of finance, Lilly USA Pharmaceutical Operations
  • Manager of corporate strategy and planning
  • Senior analyst, corporate finance and investment banking

Before joining Eli Lilly and Company, Mr. Kopp worked in various financial roles at General Motors Corp., including capital planning and manufacturing, as well as international treasury and business development support, primarily focused on Latin America.

Mr. Kopp sits on the Investment Committee of Lynx Capital Corp., a fund dedicated to providing growth capital to minority-owned businesses in Indiana.

He grew up in Northern Kentucky and Southern Indiana and holds a bachelor’s degree in finance from Indiana University and a master’s degree in business administration from Butler University.

Jackie Larew
Senior Director-Quality Assurance

Jacqueline Larew Portrait

Jacqueline (Jackie) Larew has responsibility for global quality assurance and quality control supporting all areas of Elanco, including research and development, manufacturing, contract manufacturing, sales, and marketing.
Jackie received her Ph.D. in Analytical Chemistry from Iowa State University in 1990 and joined Eli Lilly and Company in the quality control unit at their Tippecanoe Laboratories that same year.  Since that time, she has held various leadership positions spanning the entire drug development pipeline, including roles in discovery, development, manufacturing, and most recently as Sr. Director of Global Quality Laboratories.
Jackie participates in several external associations including AAPS, ACS, and IQ  and is a past chair of the PhRMA Analytical Technical Group where she led Quality by Design initiatives focused on analytical methods and control strategies.

Michael Morgan
Senior Director, Ethics and Compliance

Mike Morgan Portrait

Mike Morgan is the Senior Director, Ethics and Compliance, Elanco the animal health division of Eli Lilly and Company, is currently based in Greenfield, Indiana.
Mike has worked for Eli Lilly in the pharmaceutical industry for 27+ years and for Elanco since September 2013.  Prior to his current role, Mike was the Senior Director of Ethics and Compliance for Europe, Canada and Australia from 2009-2013 and was Director of Ethics and Compliance at the Lilly Corporate Headquarters and in the US affiliate in Indianapolis, from 2005 to 2009.  Mike has worked in a variety of other functions within Lilly including Sales/Sales Management, Marketing/Pricing, Health Economics/Health Outcomes and worked at PCS Health Systems in Disease Management.
Education:   Bachelor of Science, Molecular and Cell Biology, Pennsylvania State University  
Master of Science, Business Management, Purdue University
Certifications:  Health Care Compliance Certification Seton Hall University Law School
Certified Compliance and Ethics Professional, Society of Corporate Compliance and Ethics

C.T. Newsum
General Counsel

C.T. Newsum Portrait

C.T. is an Assistant General Counsel of Eli Lilly and Company and serves as the General Counsel of Lilly’s Elanco Animal Health business unit.  In this capacity, he is responsible for the global legal affairs of the animal health division with annual revenues of over $2B.  

Prior to joining Elanco, C.T. was Assistant General Counsel of Wyeth and served as Senior Vice President and Chief Legal Counsel for the Fort Dodge Animal Health division of Wyeth.  During his 17 year tenure at Wyeth, C.T. was involved in over $1B in acquisitions and
divestitures in the animal health industry, including Wyeth's acquisition of the worldwide animal health business of Solvay S.A., Wyeth’s purchase of Syntex Animal Health, Inc. and the divestiture of Wyeth’s medicated feed additive business to F. Hoffmann-LaRoche Limited.  C.T. also has experience in government mandated divestitures, including the FTC’s required sale by Wyeth of the former companion animal vaccine business of Solvay S.A. to Schering-Plough in the U.S. and Wyeth’s acquisition of certain poultry vaccine assets required by the FTC to be divested as part of Schering-Plough's acquisition of Organon Biosciences N.V.

C.T. received his Juris Doctorate from Creighton University School of Law and his Bachelor of Arts degree in History from the University of Iowa.


Patrick O’Leary
Regional Leader EMEA

Patrick O’Leary Portrait

Patrick O’Leary joined Eli Lilly and Company in 1982 in Kinsale, Ireland. He has held roles in finance, information technology and customer service, followed by management assignments in finance, strategic planning and production operations.

He moved to Indiana (USA) in 2000 and assumed responsibility for product manager support for Elanco’s swine portfolio in international markets. He was promoted to director in June 2001 and moved to Vienna, Austria, with sales, marketing and technical responsibility for Elanco’s operations in Central-Eastern Europe/North Africa/Middle Eastern markets.

In 2004, he returned to the Elanco global headquarters in Greenfield, Ind., and assumed the role of director of the U.S. Swine Business Unit. In January 2008, Mr. O’Leary became executive director and later vice president for all sales and marketing activities for all global affiliates, with the exception of the United States and West Europe.

He received a bachelor’s of commerce degree from the University of Cork, Ireland. He qualified as a Chartered Accountant in 1984.

Melt Van Der Spuy
Vice President, Operations (Asia and Latin America)

Melt Van Der Spuy Portrait

Melt van der Spuy, joined Eli Lilly 19 years ago as a medical representative in our South African operation. Before assuming his current role of Vice President Elanco operations (Asia Pacific & Latin America) he successfully completed various management roles in South Africa, United Kingdom, United States of America, Puerto Rico, Taiwan and India.  

Melt has a Bachelor of Pharmacy degree from NWU (North West University) in South Africa and also a certificate in Business Management from Henley, England. He is fluent in English and Afrikaans and is conversational in both Spanish and Mandarin.

William Weldon
Vice President-Global Research and Development

William Weldon Portrait

Bill is currently the Vice President for Global Research and Development at Elanco Animal Health.  His responsibilities include Elanco’s global research, development and regulatory operations, as well as emerging businesses, vaccines and enzymes.  These areas are responsible for the development and launch of new products and solutions that improve the health, wellness, wellbeing and performance of animals.  

Bill joined Elanco in 1995 and has served in various roles, primarily focusing on delivering innovation, in Elanco since that time.  During Bill’s tenure at Elanco, he has been involved with teams that have introduced several new products to the market.  His involvement has ranged from supporting new products directly in the marketplace, to his current responsibilities for delivering new products from research and development.  

A native of Michigan, Bill received his BS and MS in Animal Science from Michigan State University and received his PhD in Animal Nutrition from the University of Nebraska in 1992.  Prior to Elanco, Bill was Assistant Professor of Animal Science at Ohio State University and was a Swine Nutritionist at Newsham Hybrids USA.